From Laboratory Bench to Patient Bedside to Discerning Boardroom

Our fundamental purpose is to find and invest in early-stage assets, which improve patient outcomes, increase quality of healthcare, and prolong human longevity.

Therapeutics

We seek therapeutic assets and devices with established proof-of-concept and with established or disected mechanism of action, regardless of size of molecule or medical indication.

Devices

We strive for funding modern medical devices that lead to quicker recovery times, reduced pain and improved quality of life and facilitate personalized, data-driven healthcare decisions.

Diagnostics

We aim to find advanced technologies that significantly enhance diagnosis and treatment precision, allowing for early detection of diseases and more targeted interventions.

Health Tech

We seek companies that improve health care outcomes by utilizing real time data and sophisticated AI methodology as well as optimize work flow to address evolving health care challenges.

Investment Strategy

Our strategy is dedicated to investing in cutting-edge medical technologies and therapies that have the potential to revolutionize healthcare, decrease morbidity, improve quality of life and extend human lifespan.

Learn More

From Laboratory Bench to Patient Bedside to Discerning Boardroom

Therapeutics

Devices

Diagnostics

Health Tech

Investment Strategy

Executive Team

Gennady Bratslavsky, MD

Brooke Raphael

David Saab

Portfolio Companies

Get in touch